Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d)
about
LILRA3 binds both classical and non-classical HLA class I molecules but with reduced affinities compared to LILRB1/LILRB2: structural evidenceHLA-B*35-Px-mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulsesMultimeric structures of HLA-G isoforms function through differential binding to LILRB receptorsHLA-F is a surface marker on activated lymphocytesIg-like transcript 4 inhibits lipid antigen presentation through direct CD1d interactionModulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6--STAT3 signaling pathwayLeukocyte Ig-Like Receptors - A Model for MHC Class I Disease AssociationsSome basic aspects of HLA-G biologyControlling the Immunological Crosstalk during Conception and Pregnancy: HLA-G in ReproductionHLA-dependent tumour development: a role for tumour associate macrophages?Molecular Recognition of Paired Receptors in the Immune SystemStructure of UL18, a peptide-binding viral MHC mimic, bound to a host inhibitory receptorThe Structure and Stability of the Monomorphic HLA-G Are Influenced by the Nature of the Bound PeptideCrystal Structure of Leukocyte Ig-like Receptor LILRB4 (ILT3/LIR-5/CD85k): A MYELOID INHIBITORY RECEPTOR INVOLVED IN IMMUNE TOLERANCECrystal structures of the two membrane-proximal Ig-like domains (D3D4) of LILRB1/B2: alternative models for their involvement in peptide-HLA bindingRecent Advances in Our Understanding of HLA-G Biology: Lessons from a Wide Spectrum of Human DiseasesHLA-F and MHC-I Open Conformers Bind Natural Killer Cell Ig-Like Receptor KIR3DS1HLA-F complex without peptide binds to MHC class I protein in the open conformer form.HLA-F and MHC-I open conformers cooperate in a MHC-I antigen cross-presentation pathwayHLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptorsTolerogenic function of dimeric forms of HLA-G recombinant proteins: a comparative study in vivoSynthetic HLA-G proteins for therapeutic use in transplantation.Novel HLA-G-binding leukocyte immunoglobulin-like receptor (LILR) expression patterns in human placentas and umbilical cords.A motif in LILRB2 critical for Angptl2 binding and activation.The role of HLA-G in immunity and hematopoiesis.HLA-G as a tolerogenic molecule in transplantation and pregnancy.Impact of HLA-G analysis in prevention, diagnosis and treatment of pathological conditionsMolecular biomarkers for grass pollen immunotherapy.Immune modulation of HLA-G dimer in maternal-fetal interfaceImplications of the polymorphism of HLA-G on its function, regulation, evolution and disease association.HLA Class Ib Molecules and Immune Cells in Pregnancy and PreeclampsiaDifferential but competitive binding of Nogo protein and class i major histocompatibility complex (MHCI) to the PIR-B ectodomain provides an inhibition of cells.LILRB2 interaction with HLA class I correlates with control of HIV-1 infection.Unfavourable clinical implications for HLA-G expression in acute myeloid leukaemia.The Leukocyte Immunoglobulin-Like Receptor Family Member LILRB5 Binds to HLA-Class I Heavy Chains.Human HLA-G+ extravillous trophoblasts: Immune-activating cells that interact with decidual leukocytes.Why is placentation abnormal in preeclampsia?Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?A viral CTL escape mutation leading to immunoglobulin-like transcript 4-mediated functional inhibition of myelomonocytic cellsStructural insights into activation of antiviral NK cell responses
P2860
Q21091044-16E62327-1B2A-4E6A-B981-4DC973299CE8Q22001527-B5BDB114-C3F1-496F-9E37-865573C94CB3Q24293562-7454EF84-C818-439B-BF83-29A63D667DF3Q24300864-DF427039-259A-4284-9797-EBBDB664C1B7Q24313634-3840EEC0-6FC3-494D-A653-3E82E5744F53Q24321398-259EB107-0D86-48CC-A44E-FA4FD1C9061EQ26738439-E273682C-C41C-4994-A3CB-BEC84CDCC2B4Q26852671-C0444B0C-C96F-4087-824C-ED4074DDEB18Q26996465-A34788B0-22C2-472F-A97F-FBC21BDEBCCBQ27022124-017B21C7-1D12-4C30-9038-EBE8D85F2A16Q27500369-D2FE216E-9FD0-4F90-BD08-34888C96D1FBQ27651216-C701B1B8-E298-4C34-A63C-DD80A6BBBCF5Q27659367-8DCCEF93-808B-4AE6-88EB-0829A06F440DQ27667381-8B88B1C3-6B2A-4AAB-8469-88F24335EA96Q27679716-F5C5379A-F256-4ACF-92C2-C7E450841B9BQ28079536-49274D02-F565-4D7E-881A-5342D8B3F3C2Q28278705-22BFFFEC-01B3-47DB-A081-6C1A1593C560Q28282824-594CAB41-A3B0-4EEF-B051-C555F423AD44Q28294499-EDE1FD2A-31F2-4D3D-A90E-518F5069EB95Q28298119-F5224590-786D-4191-80B9-2F55F0886656Q28742634-AF91158B-17F4-43A6-9343-4FC9A53D6070Q30543621-AFC8DC17-2C7A-44FD-8A57-0FBDD973D318Q33341247-60377590-8404-4799-BC33-7198D6860237Q34019602-F65538C0-7C28-4680-85FE-E7EFA02003E8Q34024865-9C17F76D-46EF-45C5-9F10-4CB4EEAC8D46Q34038019-CF8A9D70-E1E4-45FA-AF98-DFA4D17E9906Q34093041-B8F8C6D0-ABEA-4D74-9809-E456F446FBB0Q34093047-9E888F3F-564E-4E41-963B-BB74DAAB8FD1Q34350160-6385F7E5-A724-4333-9463-792EE18CDCC4Q34491478-9F06ADF5-1A6E-4E3B-9CD5-86FB8624C137Q34763454-FB89E922-68B6-408F-9BC7-D50DAE67D913Q35111055-A27F045F-ABBA-41BC-9508-44F6A8AE3C15Q35112707-E08BC426-5247-4E73-9276-F0A8706A29E9Q35458400-D9D2392A-F8D0-4105-85D7-65CB184C7BC7Q35670468-E03DD1AD-F61B-402E-8162-644F095A1E29Q35740449-751B3225-9873-4828-86CB-B336E249654EQ36119044-317C3DAB-E095-4E63-B99B-228466FE21A0Q36184793-3C1A7D07-5218-41A5-BCFE-B66A545CA3B7Q36229149-4AC16B67-1410-485C-AF5C-0838FEE0DF10Q36317668-CD9E52DB-5B98-42F3-88EC-CF9389FD35C9
P2860
Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d)
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Structural basis for recogniti ...... or B2 (LILRB2/LIR2/ILT4/CD85d)
@ast
Structural basis for recogniti ...... or B2 (LILRB2/LIR2/ILT4/CD85d)
@en
type
label
Structural basis for recogniti ...... or B2 (LILRB2/LIR2/ILT4/CD85d)
@ast
Structural basis for recogniti ...... or B2 (LILRB2/LIR2/ILT4/CD85d)
@en
prefLabel
Structural basis for recogniti ...... or B2 (LILRB2/LIR2/ILT4/CD85d)
@ast
Structural basis for recogniti ...... or B2 (LILRB2/LIR2/ILT4/CD85d)
@en
P2093
P2860
P921
P356
P1476
Structural basis for recogniti ...... or B2 (LILRB2/LIR2/ILT4/CD85d)
@en
P2093
Eiji Kurimoto
Izumi Kumagai
Katsumi Maenaka
Kimiko Kuroki
Koichi Kato
Kouhei Tsumoto
Linda Rasubala
Mitsunori Shiroishi
P2860
P304
16412-16417
P356
10.1073/PNAS.0605228103
P407
P577
2006-10-20T00:00:00Z